Ophthalmic Manifestations of Hematopoietic Malignancy

Table 1

Clinical presentation and treatment result in patients with ophthalmologic manifestation of hematopoietic cancer.

Sex	Primary disease	Age of onset	Period of onset	Status	Eye disease	Therapy on eye disease	Visual acuity on first visit	Final visual acuity	Systemic outcome	Ophthalmologic outcome
M	ALL	10 y	3 y	CR	Optic nerve invasion	Chemotherapy	0.6	0.6	Recovered	Recovered
F	MM	39 y	4 y	CR	Sixth-nerve palsy	Chemotherapy	1.2	1.2	Died	Recovered
M	ARL	52 y	1 y	PD	Optic nerve invasion	No treatment	0.05	HM	Died	Deteriorated
F	MM	73 y	9 y	MR	Optic nerve invasion	Steroid pulse therapy	0.05	1.2	Deteriorated	Recovered
M	ARL	43 y	Unknown	No therapy	Optic nerve invasion	Chemo + autologous peripheral stem cell transplantation	1.2	HM	Died	Deteriorated
					Optic nerve invasion		1.2	Unknown
M	MM	47 y	4.5 y	MR	Sixth-nerve palsy	Chemotherapy	1.2	1.2	Died	Recovered
M	ARL	36 y	Unknown	No therapy	Optic nerve invasion	Chemotherapy	0.05	Unknown	Died	Deteriorated
F	Follicular lymphoma	72 y	4.7 y	PD	Optic nerve invasion	Chemotherapy	0.5	Unknown	Deteriorated	Deteriorated

ALL: acute lymphocytic leukemia; CR: complete response; ARL: AIDS-related lymphoma; PD: progressive disease; MM: multiple myeloma; MR: minor response; HM: hand motion.